Hasil Pencarian - Jieer Ying

Perbaiki Hasil
  1. 1
    Cancer cell-intrinsic PD-1: Its role in malignant progression and immunotherapy

    Cancer cell-intrinsic PD-1: Its role in malignant progression and immunotherapy oleh Muhua Chen, Lei Bie, Jieer Ying

    Diterbitkan 2023-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Gut Microbiota and Immunotherapy

    Gut Microbiota and Immunotherapy oleh Xiaoqing Xu, Xiaoqing Xu, Jieer Ying

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Anti-PD-1/L1 antibody plus anti-VEGF antibody vs. plus VEGFR-targeted TKI as first-line therapy for unresectable hepatocellular carcinoma: a network meta-analysis

    Anti-PD-1/L1 antibody plus anti-VEGF antibody vs. plus VEGFR-targeted TKI as first-line therapy for unresectable hepatocellular carcinoma: a network meta-analysis oleh Yiwen Zhou, Jingjing Li, Jieer Ying

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Therapeutic significance of tumor microenvironment in cholangiocarcinoma: focus on tumor-infiltrating T lymphocytes

    Therapeutic significance of tumor microenvironment in cholangiocarcinoma: focus on tumor-infiltrating T lymphocytes oleh Chaoqun Li, Lei Bie, Muhua Chen, Jieer Ying

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    A benzochalcone derivative synchronously induces apoptosis and ferroptosis in pancreatic cancer cells

    A benzochalcone derivative synchronously induces apoptosis and ferroptosis in pancreatic cancer cells oleh Xiaoqing Guan, Bing Zhao, Xiaodan Guan, Jinyun Dong, Jieer Ying

    Diterbitkan 2023-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Beyond ENO1, emerging roles and targeting strategies of other enolases in cancers

    Beyond ENO1, emerging roles and targeting strategies of other enolases in cancers oleh Jiaojiao Ni, Yihui Huang, Chaoqun Li, Qian Yin, Jieer Ying

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    An Active Trend of Immunotherapy Combination Regimen as Second-Line Therapy Towards Advanced Biliary Tract Cancer

    An Active Trend of Immunotherapy Combination Regimen as Second-Line Therapy Towards Advanced Biliary Tract Cancer oleh Haimin Weng, Pengfei Zeng, Yuemiao Chen, Qi Xu, Jieer Ying

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    XYA-2: a marine-derived compound targeting apoptosis and multiple signaling pathways in pancreatic cancer

    XYA-2: a marine-derived compound targeting apoptosis and multiple signaling pathways in pancreatic cancer oleh Xiaoqing Guan, Yun Li, Xiaodan Guan, Linfei Fan, Jieer Ying

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    The effect of anti-PD-1/PD-L1 antibodies combined with VEGF receptor tyrosine kinase inhibitors versus bevacizumab in unresectable hepatocellular carcinoma

    The effect of anti-PD-1/PD-L1 antibodies combined with VEGF receptor tyrosine kinase inhibitors versus bevacizumab in unresectable hepatocellular carcinoma oleh Hui Zeng, Qi Xu, Jinyu Wang, Xiaoqing Xu, Jun Luo, Lei Zhang, Cong Luo, Jieer Ying, Jingjing Li

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Intratumoral OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: a multicenter, phase I/II clinical trial

    Intratumoral OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: a multicenter, phase I/II clinical trial oleh Jialin Tang, Sheng Hu, Suxia Luo, Zhiguo Luo, Fuxiang Zhou, Shiyun Tan, Jieer Ying, Chengyun Geng, Xiangyong Gu, Binlei Liu

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Clinicopathological Characteristics and Prognosis of Signet Ring Gastric Cancer: A Population-Based Study

    Clinicopathological Characteristics and Prognosis of Signet Ring Gastric Cancer: A Population-Based Study oleh Qing Wei, Yiding Gao, Changsong Qi, Xing Yuan, Jingjing Li, Qi Xu, Cong Luo, Lei Chen, Wei Zhuo, Zhiyuan Xu, Jieer Ying

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Chebulagic acid suppresses gastric cancer by inhibiting the AURKA/β-catenin/Wnt pathway

    Chebulagic acid suppresses gastric cancer by inhibiting the AURKA/β-catenin/Wnt pathway oleh Jing Zhao, Jing Zhao, Jing Zhao, Jing Zhao, Yunfu Shi, Yunfu Shi, Yubo Ma, Yubo Ma, Yubo Ma, Yubo Ma, Libin Pan, Libin Pan, Libin Pan, Libin Pan, Yanan Wang, Yanan Wang, Yanan Wang, Yanan Wang, Li Yuan, Li Yuan, Li Yuan, Li Yuan, Jinyun Dong, Jieer Ying, Jieer Ying

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Exploring potential molecular resistance and clonal evolution in advanced HER2-positive gastric cancer under trastuzumab therapy

    Exploring potential molecular resistance and clonal evolution in advanced HER2-positive gastric cancer under trastuzumab therapy oleh Qi Xu, Xiaoqing Xu, Haimeng Tang, Junrong Yan, Jingjing Li, Hua Bao, Xue Wu, Yang Shao, Cong Luo, Haimin Wen, Jianying Jin, Jieer Ying

    Diterbitkan 2023-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Additive effects of variants of unknown significance in replication repair-associated DNA polymerase genes on mutational burden and prognosis across diverse cancers

    Additive effects of variants of unknown significance in replication repair-associated DNA polymerase genes on mutational burden and prognosis across diverse cancers oleh Lin Yang, Hua Bao, Xue Wu, Yong Wu, Yang Shao, Jiani C Yin, Jieer Ying, Xiangdong Cheng, Guojie Xia, Minyan Xing, Xiaoxi Chen, Jiaohui Pang, Lingjun Zhu

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II study

    Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II study oleh Ruihua Xu, Xianjun Yu, Jihui Hao, Liwei Wang, Hongming Pan, Guohong Han, Jianming Xu, Yanqiao Zhang, Shujun Yang, Jia Chen, Jieer Ying, Guanghai Dai, Mingyu Li, Damir Begic, Brian Lu, Lin Shen

    Diterbitkan 2017-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors

    The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors oleh Qing Wei, Peijing Li, Teng Yang, Jiayu Zhu, Lu Sun, Ziwen Zhang, Lu Wang, Xuefei Tian, Jiahui Chen, Can Hu, Junli Xue, Letao Ma, Takaya Shimura, Jianmin Fang, Jieer Ying, Peng Guo, Xiangdong Cheng

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol

    Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III m... oleh Xiangdong Cheng, Dan Wu, Nong Xu, Luchuan Chen, Zhilong Yan, Ping Chen, Lei Zhou, Jianfa Yu, Jiuwei Cui, Wei Li, Chang Wang, Wenming Feng, Yunhai Wei, Pengfei Yu, Yian Du, Jieer Ying, Zhiyuan Xu, Litao Yang, Yunli Zhang

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes

    Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes oleh Jing Liu, Zhaoxia Wang, Yan Shi, Xue Li, Jun Zhou, Yongqian Shu, Yunpeng Liu, Jingdong Zhang, Xiaofeng Chen, Yang Shao, Fengjiao Zhao, Dongqin Zhu, Xiangcheng Li, Jieer Ying, Deqiang Wang, Jingrong Qiu, Haizhou Lou, Jiuwei Cui, Lanlan Pan, Jianyi Zhao, Shiqing Chen, Liuqing Zhu

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Integrative clinical and molecular analysis of advanced biliary tract cancers on immune checkpoint blockade reveals potential markers of response

    Integrative clinical and molecular analysis of advanced biliary tract cancers on immune checkpoint blockade reveals potential markers of response oleh Jingjing Li, Qing Wei, Xiaoying Wu, Jun Sima, Qi Xu, Mengmeng Wu, Fufeng Wang, Haibo Mou, Hanguang Hu, Jianguo Zhao, Da Li, Jinlin Hu, Lingnan Zhang, Xiu Zhu, Lei Chen, Cong Luo, Junrong Yan, Jiachen He, Yutong Ma, Yang Shao, Wei Wu, Jieer Ying

    Diterbitkan 2020-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial

    Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial oleh Dan Liu, Jun Zhou, Yongsheng Wang, Mingjun Li, Haiping Jiang, Yunpeng Liu, Xianli Yin, Minghua Ge, Xiaojun Xiang, Jieer Ying, Jian Huang, Yan-qiao Zhang, Ying Cheng, Zhigang Huang, Xianglin Yuan, Weiqing Han, Dong Yan, Xinshuai Wang, Pan Liu, Linna Wang, Xiaojing Zhang, Suxia Luo, Tianshu Liu, Lin Shen

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: